Related references
Note: Only part of the references are listed.The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice
Chunfen Mo et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease
Gregory R. Steinberg et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
The discovery of first-in-class drugs: origins and evolution
Joerg Eder et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
A multimodal Darwinian strategy for alleviating the atherosclerosis pandemic
Geetha Mathew et al.
MEDICAL HYPOTHESES (2014)
Tissue-specific tumor suppression by BRCA1
Eva Y. -H. P. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion
Maria A. Martin-Martinez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
The value of translational biomarkers to phenotypic assays
David C. Swinney
FRONTIERS IN PHARMACOLOGY (2014)
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
D. C. Swinney
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Polypharmacology in a Single Drug: Multitarget Drugs
M. L. Bolognesi
CURRENT MEDICINAL CHEMISTRY (2013)
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
D. Grahame Hardie
DIABETES (2013)
Shifting from the single to the multitarget paradigm in drug discovery
Jose L. Medina-Franco et al.
DRUG DISCOVERY TODAY (2013)
Phenotypic screens as a renewed approach for drug discovery
Wei Zheng et al.
DRUG DISCOVERY TODAY (2013)
Metabolism of inflammation limited by AMPK and pseudo-starvation
Luke A. J. O'Neill et al.
NATURE (2013)
AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network
Antero Salminen et al.
AGEING RESEARCH REVIEWS (2012)
Chemotography for multi-target SAR analysis in the context of biological pathways
Eugen Lounkine et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats
Ho-Jae Lee et al.
BMC GASTROENTEROLOGY (2012)
The Helicobacter Pylori Protein HspB Interferes With Nrf2/Keap1 Pathway Altering The Antioxidant Response of Ags Cells
Elisabetta Buommino et al.
HELICOBACTER (2012)
Th2 Skewing by Activation of Nrf2 in CD4+ T Cells
Cheryl E. Rockwell et al.
JOURNAL OF IMMUNOLOGY (2012)
Abbott boosts investment in NRF2 activators for reducing oxidative stress
Sarah Crunkhorn
NATURE REVIEWS DRUG DISCOVERY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multi-Target Drugs: The Trend of Drug Research and Development
Jin-Jian Lu et al.
PLOS ONE (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Metabolic pathways in T cell fate and function
Valerie A. Gerriets et al.
TRENDS IN IMMUNOLOGY (2012)
5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Vijay Mor et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Role of dendritic cells: a step forward for the hygiene hypothesis
Xi Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway
Miao Yu et al.
CELLULAR SIGNALLING (2011)
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek et al.
JOURNAL OF IMMUNOLOGY (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation
Ryan D. Michalek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis
Aiping Bai et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The complicated role of NF-kappa B in T-cell selection
Mingzhao Zhu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Reduction of AMP-Activated Protein Kinase α2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo
Yunzhou Dong et al.
CIRCULATION (2010)
The 'hygiene hypothesis' for autoimmune and allergic diseases: an update
H. Okada et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Gastroprotective effects of the insulin sensitizers rosiglitazone and metformin against indomethacin-induced gastric ulcers in Type 2 diabetic rats
Mohamed A. Morsy et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Precarious Balance: Th17 Cells in Host Defense
Ariana Peck et al.
INFECTION AND IMMUNITY (2010)
Redox Regulation of Lipopolysaccharide-mediated Sulfiredoxin Induction, Which Depends on Both AP-1 and Nrf2
Hojin Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Novel Anti-Inflammatory Action of 5-Aminoimidazole-4-carboxamide Ribonucleoside with Protective Effect in Dextran Sulfate Sodium-Induced Acute and Chronic Colitis
Aiping Bai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Synthetic immunology to engineer human immunity
David A. Spiegel
NATURE CHEMICAL BIOLOGY (2010)
Cardiovascular Complications of Rheumatoid Arthritis: Assessment, Prevention, and Treatment
Mariana J. Kaplan
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2010)
Evolutionary inspirations for drug discovery
Hong-Yu Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
AMPK and the biochemistry of exercise: implications for human health and disease
Erik A. Richter et al.
BIOCHEMICAL JOURNAL (2009)
Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
A. Peairs et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
M. Galgani et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid-Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin
Xiao-Nan Li et al.
DIABETES (2009)
Materials engineering for immunomodulation
Jeffrey A. Hubbell et al.
NATURE (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
GITR signaling potentiates airway hyperresponsiveness by enhancing Th2 cell activity in a mouse model of asthma
Alexandre C. Motta et al.
RESPIRATORY RESEARCH (2009)
Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions
Kazuki Ueda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter
Marc A. Williams et al.
JOURNAL OF IMMUNOLOGY (2008)
Nrf2 as a Master Redox Switch in Turning on the Cellular Signaling Involved in the Induction of Cytoprotective Genes by Some Chemopreventive Phytochemicals
Young-Joon Surh et al.
PLANTA MEDICA (2008)
Natural products as sources of new drugs over the last 25 years
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells
K Isoda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Metformin inhibits cytokine-induced nuclear factor kappa B activation via AMP-activated protein kinase activation in vascular endothelial cells
Yoshiyuki Hattori et al.
HYPERTENSION (2006)
Th17: An effector CD4 T cell lineage with regulatory T cell ties
Casey T. Weaver et al.
IMMUNITY (2006)
Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines
E Mortaz et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12),(14)-prostaglandin J(2)
K Itoh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Tea pigments inhibit the production of type 1 (TH1) and type 2 (TH2) helper T cell cytokines in CD4+ T cells
M Tomita et al.
PHYTOTHERAPY RESEARCH (2002)
Share Paper
